Roquette Names Barentz as Strategic Distribution Partner for Pharmaceuticals in the US
Roquette, a leading company in plant-based ingredients, plant proteins and pharmaceutical excipients, has appointed Barentz as its strategic partner for the distribution of pharmaceutical and nutraceutical products in the United States.
Barentz and Roquette have successfully worked together for many years in several European countries, developing distribution channels supported by strong technical expertise. This is part of the high-performance distribution network that Roquette has implemented to support its position as a leading pharmaceutical excipient company. This appointment brings this technical expertise to the United States, where both companies will benefit from a strategic partnership that will enable their growth in the pharmaceutical market.
Paul Smaltz, Head of Roquette Global Pharma Business Unit, said, "I am pleased to say that Barentz will advance our entire Roquette portfolio for our customers. As we grow our business and expand through acquisitions and innovation, Barentz gives us a partner with strategic focus on the pharmaceutical market and global reach. Similarly, Barentz is investing in the US with a strong partner behind it, namely Roquette, and expanding its footprint in pharmaceutical excipients."
This strategic partnership in the US is a logical next step in the ongoing successful relationship between Roquette and Barentz.
Torsten Pieschnick, Vice President/Board Member of Barentz, said, "We are extremely pleased and honored to expand our highly successful partnership with Roquette's Pharma Global Business Unit in the US. Our pharmaceutical department, led by Vice President of Global Pharma Anthony Litchfield, is focused on providing leading service and technical support to the pharmaceutical and nutraceutical sectors.
Combining our strengths with Roquette in the US will certainly help Barentz to successfully bring our solutions and leading service to this market, which we will expand to our customer base. A dedicated local team led by Kelly Blanch, US Pharma Regional Vice President, is ready to do this commitment."
